Abstracts
Jean-Michel Derlon(Commissariat à l'Énergie Atomique et aux Énergies Alternatives), Andreas Frank(Orthopädische Praxis), Benoît Pirotte(Erasmus Hospital), F. Dauphin(Commissariat à l'Énergie Atomique et aux Énergies Alternatives), F. X. Weinzierl(Technical University of Munich), A. Stevenaert, Ronald G. Blasberg(Memorial Sloan Kettering Cancer Center), B. Kaschten, Steven M. Larson(Memorial Sloan Kettering Cancer Center), Pauline A. Filipek(University of California, Irvine), Bradley J. Beattie(Memorial Sloan Kettering Cancer Center), David N. Kennedy(Massachusetts General Hospital), F. Darcel(Commissariat à l'Énergie Atomique et aux Énergies Alternatives), W. E. Goebel(Technical University of Munich), James Z. Ginos(Memorial Sloan Kettering Cancer Center), M. S. Jiaju Zhang(Memorial Sloan Kettering Cancer Center), E. L. Mooyaart(University of Groningen), A. J. Fishman(Massachusetts General Hospital), Mathieu Gross(Technical University of Munich), B. Sadzot, M. Oudksrk(Rotterdam University of Applied Sciences), F. Chapon(Commissariat à l'Énergie Atomique et aux Énergies Alternatives), A. Trappe(Technical University of Munich), R. L. Kamman(University of Groningen), M. Levivier(Erasmus Hospital), René J. Metz(Massachusetts General Hospital), Farhad Daghighian(Memorial Sloan Kettering Cancer Center), Homer A. Macapinlac(International Atomic Energy Agency), M. A. A. M. Heesters(University of Groningen), Jacques Brotchi(Erasmus Hospital), Peter C. Levendag(Erasmus MC Cancer Institute), F. Hochberg, Paul E. Sijens(Rotterdam University of Applied Sciences), Serge Goldman, André Luxen(Erasmus Hospital), P. Creissard(Commissariat à l'Énergie Atomique et aux Énergies Alternatives), Danielle Balériaux, Ronald D. Finn(Memorial Sloan Kettering Cancer Center), Martin C. Graham(Memorial Sloan Kettering Cancer Center), K. G. Go(University of Groningen), Ch.J. Vecht(Rotterdam University of Applied Sciences), B.R. Rosen(Massachusetts General Hospital), J.-M. Brucher(Erasmus Hospital), J P Houtteville(Commissariat à l'Énergie Atomique et aux Énergies Alternatives), Jerzy Hildebrand(Erasmus Hospital), Pieter van Dijk(Rotterdam University of Applied Sciences), M. C. Petit-taboué(Commissariat à l'Énergie Atomique et aux Énergies Alternatives), V. S. Caviness(Harvard University), P. Courtheoux(Commissariat à l'Énergie Atomique et aux Énergies Alternatives)
Cited by 1
Related Papers
Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1–2 study
|The Lancet|2010|1.1k
Practice parameter: Screening and diagnosis of autism
|Neurology|2000|1.1k
The Screening and Diagnosis of Autistic Spectrum Disorders
|Journal of Autism and Developmental Disorders|1999|1k
Structural Brain Magnetic Resonance Imaging of Limbic and Thalamic Volumes in Pediatric Bipolar Disorder
|American Journal of Psychiatry|2005|835
Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid Cancer
|New England Journal of Medicine|2013|825